ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Subscribe To Our Newsletter & Stay Updated